Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016

Benzer Materyaller

• Meningococcal Carriage Following a University Serogroup B Meningococcal Disease Outbreak and Vaccination Campaign with MenB-4C and MenB-FHbp — Oregon, 2015–2016
  Yazar:: McNamara, Lucy A., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
  Yazar:: Folaranmi, Temitope, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
  Yazar:: Mbaeyi, Sarah A., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease
  Yazar:: Harrison, Robyn, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
  Yazar:: Rubin, Lorry, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)